Literature DB >> 18981290

N-Glycans of ADAMTS13 modulate its secretion and von Willebrand factor cleaving activity.

Wenhua Zhou1, Han-Mou Tsai.   

Abstract

Severe deficiency of ADAMTS13, a plasma metalloprotease, leads to thrombotic thrombocytopenic purpura. ADAMTS13 contains 10 putative N-glycosylation sites in or near its metalloprotease sequence, spacer region, thrombospondin type 1 repeat no. 4 (TSR no. 4), and CUB domains. Tunicamycin treatment markedly decreased the secretion of ADAMTS13 into the culture medium of transfected cells. Nevertheless, the protease was efficiently secreted from N-acetylglucosaminyltransferase I-deficient Lec1 Chinese hamster ovary cells, indicating that N-glycosylation in the endoplasmic reticulum, but not the conversion of oligomannose to complex N-glycans in the Golgi complex, is important for secretion. However, ADAMTS13 with oligomannose N-glycans cleaved its substrate, von Willebrand factor (VWF) multimers, less effectively, with a higher K(m) but similar k(cat) value. In mutagenesis analysis, decreased secretion and VWF cleaving activity was observed with the N146Q and N828Q mutants, while decreased secretion only was observed with the N552Q mutant of ADAMTS13. Enzymatic removal of N-glycans from ADAMTS13 did not affect its VWF cleaving activity. Thus, N-glycosylation is necessary for efficient secretion of ADAMTS13, while conversion of the N-glycans from oligomannose to complex type in the Golgi complex enhances the proteolytic activity of the protease toward VWF multimers. After its secretion, ADAMTS13 does not require N-glycans for its VWF cleaving activity.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18981290      PMCID: PMC2630278          DOI: 10.1182/blood-2008-07-167775

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  21 in total

1.  Chinese hamster ovary cells selected for resistance to the cytotoxicity of phytohemagglutinin are deficient in a UDP-N-acetylglucosamine--glycoprotein N-acetylglucosaminyltransferase activity.

Authors:  P Stanley; S Narasimhan; L Siminovitch; H Schachter
Journal:  Proc Natl Acad Sci U S A       Date:  1975-09       Impact factor: 11.205

Review 2.  Current concepts in thrombotic thrombocytopenic purpura.

Authors:  Han-Mou Tsai
Journal:  Annu Rev Med       Date:  2006       Impact factor: 13.739

3.  Enzymatically active ADAMTS13 variants are not inhibited by anti-ADAMTS13 autoantibodies: a novel therapeutic strategy?

Authors:  Wenhua Zhou; Lingli Dong; David Ginsburg; Eric E Bouhassira; Han-Mou Tsai
Journal:  J Biol Chem       Date:  2005-10-03       Impact factor: 5.157

Review 4.  Biosynthetic protein transport and sorting by the endoplasmic reticulum and Golgi.

Authors:  S R Pfeffer; J E Rothman
Journal:  Annu Rev Biochem       Date:  1987       Impact factor: 23.643

5.  Glycoforms modify the dynamic stability and functional activity of an enzyme.

Authors:  P M Rudd; H C Joao; E Coghill; P Fiten; M R Saunders; G Opdenakker; R A Dwek
Journal:  Biochemistry       Date:  1994-01-11       Impact factor: 3.162

6.  ADAMTS13 is expressed in hepatic stellate cells.

Authors:  Wenhua Zhou; Mari Inada; Tai-Ping Lee; Daniel Benten; Sergey Lyubsky; Eric E Bouhassira; Sanjeev Gupta; Han-Mou Tsai
Journal:  Lab Invest       Date:  2005-06       Impact factor: 5.662

7.  Apical sorting of ADAMTS13 in vascular endothelial cells and Madin-Darby canine kidney cells depends on the CUB domains and their association with lipid rafts.

Authors:  Dezhi Shang; X Wu Zheng; Masami Niiya; X Long Zheng
Journal:  Blood       Date:  2006-04-04       Impact factor: 22.113

8.  Human endothelial cells synthesize and release ADAMTS-13.

Authors:  N Turner; L Nolasco; Z Tao; J-F Dong; J Moake
Journal:  J Thromb Haemost       Date:  2006-06       Impact factor: 5.824

9.  Localization of ADAMTS13 to the stellate cells of human liver.

Authors:  Masahito Uemura; Kouko Tatsumi; Masanori Matsumoto; Masao Fujimoto; Tomomi Matsuyama; Masatoshi Ishikawa; Taka-Aki Iwamoto; Toshio Mori; Akio Wanaka; Hiroshi Fukui; Yoshihiro Fujimura
Journal:  Blood       Date:  2005-04-26       Impact factor: 22.113

10.  Selection and characterization of eight phenotypically distinct lines of lectin-resistant Chinese hamster ovary cell.

Authors:  P Stanley; V Caillibot; L Siminovitch
Journal:  Cell       Date:  1975-10       Impact factor: 41.582

View more
  9 in total

1.  N-linked glycosylation of dengue virus NS1 protein modulates secretion, cell-surface expression, hexamer stability, and interactions with human complement.

Authors:  Pawit Somnuke; Richard E Hauhart; John P Atkinson; Michael S Diamond; Panisadee Avirutnan
Journal:  Virology       Date:  2011-03-22       Impact factor: 3.616

2.  ADAMDEC1 is a metzincin metalloprotease with dampened proteolytic activity.

Authors:  Jacob Lund; Ole H Olsen; Esben S Sørensen; Henning R Stennicke; Helle H Petersen; Michael T Overgaard
Journal:  J Biol Chem       Date:  2013-06-10       Impact factor: 5.157

3.  Idiopathic noncirrhotic intrahepatic portal hypertension is associated with sustained ADAMTS13 Deficiency.

Authors:  Ian Mackie; C E Eapen; Desley Neil; Andrew S Lawrie; Andrew Chitolie; Jean C Shaw; Elwyn Elias
Journal:  Dig Dis Sci       Date:  2011-05-15       Impact factor: 3.199

4.  Cyclosporin A impairs the secretion and activity of ADAMTS13 (a disintegrin and metalloprotease with thrombospondin type 1 repeat).

Authors:  Klilah Hershko; Vijaya L Simhadri; Adam Blaisdell; Ryan C Hunt; Jordan Newell; Sandra C Tseng; Alon Y Hershko; Jae Won Choi; Zuben E Sauna; Andrew Wu; Richard J Bram; Anton A Komar; Chava Kimchi-Sarfaty
Journal:  J Biol Chem       Date:  2012-11-09       Impact factor: 5.157

Review 5.  Pathophysiology of thrombotic thrombocytopenic purpura.

Authors:  Han-Mou Tsai
Journal:  Int J Hematol       Date:  2010-01       Impact factor: 2.490

6.  N-glycosylation of carnosinase influences protein secretion and enzyme activity: implications for hyperglycemia.

Authors:  Eva Riedl; Hannes Koeppel; Frederick Pfister; Verena Peters; Sibylle Sauerhoefer; Paula Sternik; Paul Brinkkoetter; Hanswalter Zentgraf; Gerjan Navis; Robert H Henning; Jacob Van Den Born; Stephan J L Bakker; Bart Janssen; Fokko J van der Woude; Benito A Yard
Journal:  Diabetes       Date:  2010-05-11       Impact factor: 9.461

7.  Generation and validation of small ADAMTS13 fragments for epitope mapping of anti-ADAMTS13 autoantibodies in immune-mediated thrombotic thrombocytopenic purpura.

Authors:  Kadri Kangro; Elien Roose; An-Sofie Schelpe; Edwige Tellier; Gilles Kaplanski; Jan Voorberg; Simon F De Meyer; Andres Männik; Karen Vanhoorelbeke
Journal:  Res Pract Thromb Haemost       Date:  2020-06-25

8.  Prediction of spacer-α6 complex: a novel insight into binding of ADAMTS13 with A2 domain of von Willebrand factor under forces.

Authors:  Xiang Fang; Jiangguo Lin; Ying Fang; Jianhua Wu
Journal:  Sci Rep       Date:  2018-04-10       Impact factor: 4.379

Review 9.  Platelets and Defective N-Glycosylation.

Authors:  Elmina Mammadova-Bach; Jaak Jaeken; Thomas Gudermann; Attila Braun
Journal:  Int J Mol Sci       Date:  2020-08-06       Impact factor: 5.923

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.